Orbimed Advisors - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$98,408,520
+10.6%
2,169,5000.0%2.09%
+29.6%
Q2 2023$89,014,585
+17.2%
2,169,500
+2.1%
1.61%
+8.2%
Q1 2023$75,929,630
+0.8%
2,124,500
+6.6%
1.49%
+3.5%
Q4 2022$75,298,272
+121.4%
1,993,600
+159.3%
1.44%
+128.2%
Q3 2022$34,008,000
+102.6%
768,900
+69.6%
0.63%
+107.6%
Q2 2022$16,785,000
+159.9%
453,400
+324.1%
0.30%
+230.4%
Q4 2019$6,458,000106,9000.09%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
BB BIOTECH AG 6,913,172$330,657,00012.25%
TANAKA CAPITAL MANAGEMENT INC 84,953$4,063,0009.51%
Sicart Associates LLC 280,315$13,407,0009.26%
DOWLING & YAHNKE LLC 675,843$32,326,0003.62%
Opus Point Partners Management, LLC 77,550$3,709,0002.96%
Motley Fool Asset Management LLC 259,000$12,388,0002.75%
Motley Fool Wealth Management, LLC 333,604$15,956,0001.70%
ALTRINSIC GLOBAL ADVISORS LLC 921,174$44,060,0001.63%
PINNACLE ASSOCIATES LTD 1,572,045$75,191,0001.52%
Sonora Investment Management, LLC 121,703$5,821,054,0001.20%
View complete list of IONIS PHARMACEUTICALS INC shareholders